NEW YORK--(BUSINESS WIRE)--Neuro-Hitech, Inc. a biopharmaceutical company focused on the development and commercialization of next-generation compounds against proven targets for neurodegenerative diseases, today announced that it will begin trading on the NASDAQ Capital Market under the symbol NHPI at the opening of trading on Tuesday, April 24, 2007. The Company’s stock previously traded on the OTC Bulletin Board.
